slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4.080 KRW | -0,24% | +3,29% | -6,42% |
2023 | GeneBioTech Co, Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2022 | 82,76 mld. 60,58 mln. 55,94 mln. | Omzet 2023 | 79,48 mld. 58,18 mln. 53,73 mln. | Marktkapitalisatie | 37,54 mld. 27,48 mln. 25,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 1,52 mld. 1,11 mln. 1,03 mln. | Nettowinst (verlies) 2023 | 2,59 mld. 1,9 mln. 1,75 mln. | EV/omzet 2022 | 0,38 x |
Nettoliquiditeiten 2022 | 3,06 mld. 2,24 mln. 2,07 mln. | Nettoliquiditeiten 2023 | 9,51 mld. 6,96 mln. 6,43 mln. | EV/omzet 2023 | 0,35 x |
K/w-verhouding 2022 |
22,6
x | K/w-verhouding 2023 |
14,5
x | Werknemers | 39 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 70,76% |
1 dag | -0,24% | ||
1 week | +3,29% | ||
Lopende maand | +5,15% | ||
1 maand | +4,62% | ||
3 maanden | -3,77% | ||
6 maanden | -5,12% | ||
Lopend jaar | -6,42% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chan-Ho Lee
CEO | Chief Executive Officer | 60 | - |
Joo-Sun Park
BRD | Director/Board Member | 49 | - |
Won-Tak Cho
BRD | Director/Board Member | 55 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chan-Ho Lee
CEO | Chief Executive Officer | 60 | - |
Jeong-Seon Kang
PRN | Corporate Officer/Principal | 60 | - |
Won-Tak Cho
BRD | Director/Board Member | 55 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 4.080 | -0,24% | 71 351 |
23-05-24 | 4.090 | +1,24% | 122 125 |
22-05-24 | 4.040 | +1,00% | 1 492 381 |
21-05-24 | 4.000 | +1,39% | 47 406 |
20-05-24 | 3.945 | -0,13% | 33 540 |
slotkoers Korea S.E., 24 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-6,42% | 25,73 mln. | |
+38,51% | 727 mld. | |
+33,05% | 599 mld. | |
-6,23% | 354 mld. | |
+18,78% | 328 mld. | |
+1,35% | 277 mld. | |
+16,00% | 243 mld. | |
+8,09% | 205 mld. | |
-5,77% | 203 mld. | |
+6,19% | 164 mld. |